Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.

Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, Nelson CA, Dai YN, Hall PD, Jedrzejczak RP, Joachimiak A, Krammer F, Diamond MS, Fremont DH, Kawaoka Y, Wilson PC

Open source

DOI: 10.1016/j.immuni.2021.05.001
Published: 2021 Jun 8
Container: Immunity
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.immuni.2021.05.001,
  title = {Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.},
  author = {Dugan HL and Stamper CT and Li L and Changrob S and Asby NW and Halfmann PJ and Zheng NY and Huang M and Shaw DG and Cobb MS and Erickson SA and Guthmiller JJ and Stovicek O and Wang J and Winkler ES and Madariaga ML and Shanmugarajah K and Jansen MO and Amanat F and Stewart I and Utset HA and Huang J and Nelson CA and Dai YN and Hall PD and Jedrzejczak RP and Joachimiak A and Krammer F and Diamond MS and Fremont DH and Kawaoka Y and Wilson PC},
  year = {2021},
  journal = {Immunity},
  doi = {10.1016/j.immuni.2021.05.001},
  url = {https://doi.org/10.1016/j.immuni.2021.05.001}
}

RIS

TY  - JOUR
TI  - Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
AU  - Dugan HL
AU  - Stamper CT
AU  - Li L
AU  - Changrob S
AU  - Asby NW
AU  - Halfmann PJ
AU  - Zheng NY
AU  - Huang M
AU  - Shaw DG
AU  - Cobb MS
AU  - Erickson SA
AU  - Guthmiller JJ
AU  - Stovicek O
AU  - Wang J
AU  - Winkler ES
AU  - Madariaga ML
AU  - Shanmugarajah K
AU  - Jansen MO
AU  - Amanat F
AU  - Stewart I
AU  - Utset HA
AU  - Huang J
AU  - Nelson CA
AU  - Dai YN
AU  - Hall PD
AU  - Jedrzejczak RP
AU  - Joachimiak A
AU  - Krammer F
AU  - Diamond MS
AU  - Fremont DH
AU  - Kawaoka Y
AU  - Wilson PC
PY  - 2021
JO  - Immunity
DO  - 10.1016/j.immuni.2021.05.001
UR  - https://doi.org/10.1016/j.immuni.2021.05.001
ER  -

APA

HL, D., CT, S., L, L., S, C., NW, A., PJ, H., NY, Z., M, H., DG, S., MS, C., SA, E., JJ, G., O, S., J, W., ES, W., ML, M., K, S., MO, J., F, A., I, S., HA, U., J, H., CA, N., YN, D., PD, H., RP, J., A, J., F, K., MS, D., DH, F., Y, K., & PC, W. (2021). Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.. Immunity. https://doi.org/10.1016/j.immuni.2021.05.001

Source records

pubmed · retrieved 2026-09-25T11:50:55.267Z